Half of all GP practices in New Zealand have closed their books to new patients. This means people are going on emergency departments for care – with deadly outcomes when it comes to lung cancer.
Academic rigour, journalistic flair
Articles on Lung cancer
Displaying 1 - 20 of 73 articles
Green algae carry drug-loaded nanoparticles directly to the lungs, reducing side effects in other organs and increasing treatment efficiency.
Stigma, fear and cost prevent many patients from getting screened for lung cancer. This can prove deadly for the most vulnerable.
Reducing particle pollution can save thousands of lives, but states need more data to inform better controls. An atmospheric scientist explains what data and actions are needed.
Treatment for lung cancer patients is the same for everyone, regardless of the risk of recurrence. The use of a new technology could refine diagnosis.
Tobacco harms the very structure of our cells, and affects almost every part of our bodies and nervous systems.
On Feb. 7, 2024, the EPA strengthened the federal limit for annual levels of fine particulate air pollution, or PM2.5. Many serious health effects have been linked to PM2.5 exposure.
Engineered stone is a popular material often used for kitchen benches. But it carries serious health risks for the tradies who work with it.
Since 1990, there’s been a nearly 80% increase in the number of under-50s being diagnosed with cancer globally.
Clinical trials have demonstrated the health benefits of cannabis for certain conditions, but many aren’t testing smoked or vaped forms. Research on cannabis smoke is raising concerns.
As hip-hop turns 50, an unfortunate reality is that so many of its pioneering artists never live to see much more than 50 years themselves, a professor of hip-hop writes.
Older smokers and former smokers will be invited to have their lungs scanned under a new screening programme the NHS is rolling out.
A new screening programme will increase five-year survival for people with lung cancer. But here’s what that really means.
The success of anti-smoking campaigns has come with growing stigma around lung cancer. Over one quarter of Australians admit they have less sympathy for lung cancer sufferers.
There is no one-size-fits-all approach to treating cancer. Understanding how cancer cells evolve could help researchers develop more effective drugs.
It’s often said if cigarettes were invented tomorrow, and we knew now what we didn’t know then, they would be banned outright. But vaping is showing us we’re repeating the same mistakes.
While lung cancer rates have decreased by 43% in men, they have risen by 79% in women. New screening guidelines and recognizing early symptoms can help address the changing face of lung cancer.
Health guidelines can feel contradictory and hard to interpret. But a new star rating system should help consumers and policymakers better parse the evidence behind health risks and outcomes.
The proposed standard would lower the nicotine content in cigarettes and cigars by 95% – a public health proposal that could prevent millions from becoming smokers in the first place.
Despite the popular belief that vitamin E and beta carotene supplements help prevent heart disease and cancer, the latest research suggests they do not – but the supplements do have potential risks.
Top contributors
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
Professor of Epidemiology, Curtin University
-
Adjunct Senior Lecturer, Centre for Primary Health Care and Equity, University of New South Wales, UNSW Sydney
-
Professor of Sociology & Director, Sydney Centre for Healthy Societies, University of Sydney
-
Emeritus Professor in Public Health, University of Sydney
-
Senior Research Fellow, School of Population Health, Curtin University
-
Professor at University of Melbourne and Research Fellow, Cancer Council Victoria
-
Chancellor's Professor of Medicine, Liberal Arts, and Philanthropy, Indiana University
-
Adjunct Professor, School of Psychology, Curtin University and College of Health and Medicine, Australian National University
-
Professor of Medicine, University of California, San Francisco
-
Professor and Dean, School of Public Health, Georgia State University
-
Professor in Molecular and Clinical Cancer Medicine, University of Liverpool
-
Professor and NHMRC Australian Fellow, Medicine, University of Sydney
-
Professor, Department of Hematology and Medical Oncology, Emory University
-
Professor and Director of the National Drug and Alcohol Research Centre, UNSW Sydney
